Literature DB >> 8189403

Anticipatory and residual effects of an active coping task on pre- and post-stress baselines.

W Gerin1, C Pieper, T G Pickering.   

Abstract

This study examined several issues concerning baseline measurement in cardiovascular reactivity testing: effects of anticipation of stress on baseline, point at which initial baseline stabilizes, effects of a stressful task on a succeeding baseline, and gender differences in baseline patterns. Ten males and ten females sat for a 30-min initial baseline period, a 2-min stressor (mental arithmetic), and a 15-min post-stress period. An additional ten males and ten females participated only in the 30-min initial baseline (no stressor). There was no difference in initial baseline between the stress and no-stress conditions; nor were there interactions between this factor and gender. Initial baseline stabilized at resting levels after approximately one minute. Post-stress rest levels were significantly higher than initial baseline levels for blood pressure (5.8 and 4.8 mmHg for systolic and diastolic pressure, respectively), but not for heart rate. Implications of recovery of baseline are discussed.

Mesh:

Year:  1994        PMID: 8189403     DOI: 10.1016/0022-3999(94)90087-6

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  3 in total

1.  Effects of single and repeated cognitive tasks on autonomic balance as observed by an analysis of R-R intervals.

Authors:  M Takahashi; H Arito
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

2.  Cardiovascular reactivity to a new mental stress test: The maze test.

Authors:  C Mounier-Vehier; A Girard; S Consoli; D Laude; A Vacheron; J -L Elghozi
Journal:  Clin Auton Res       Date:  1995-06       Impact factor: 4.435

3.  Laboratory-based blood pressure recovery is a predictor of ambulatory blood pressure.

Authors:  Ranak Trivedi; Andrew Sherwood; Timothy J Strauman; James A Blumenthal
Journal:  Biol Psychol       Date:  2007-11-17       Impact factor: 3.251

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.